Logo image of FF.MI

FINE FOODS & PHARMACEUTICALS (FF.MI) Stock Price, Forecast & Analysis

Europe - Euronext Milan - BIT:FF - IT0005215329 - Common Stock

9.81 EUR
+0.09 (+0.93%)
Last: 1/15/2026, 10:50:00 AM

FF.MI Key Statistics, Chart & Performance

Key Statistics
Market Cap216.41M
Revenue(TTM)373.66M
Net Income(TTM)18.62M
Shares22.06M
Float9.22M
52 Week High10.05
52 Week Low6.46
Yearly Dividend0.12
Dividend Yield1.5%
EPS(TTM)0.89
PE11.02
Fwd PE13.97
Earnings (Next)03-11
IPO2016-10-19
Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
FF.MI short term performance overview.The bars show the price performance of FF.MI in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 5 10 15 20

FF.MI long term performance overview.The bars show the price performance of FF.MI in the last 1, 2 and 3 years. 1 year 2 years 3 years 5 10 15

The current stock price of FF.MI is 9.81 EUR. In the past month the price increased by 0.62%. In the past year, price increased by 18.83%.

FINE FOODS & PHARMACEUTICALS / FF Daily stock chart

FF.MI Technical Analysis

ChartMill assigns a technical rating of 7 / 10 to FF.MI. When comparing the yearly performance of all stocks, FF.MI turns out to be only a medium performer in the overall market: it outperformed 56.19% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

FF.MI Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to FF.MI. Both the profitability and the financial health of FF.MI get a neutral evaluation. Nothing too spectacular is happening here.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

FF.MI Financial Highlights

Over the last trailing twelve months FF.MI reported a non-GAAP Earnings per Share(EPS) of 0.89. The EPS increased by 147.03% compared to the year before.


Industry RankSector Rank
PM (TTM) 5.07%
ROA 6.89%
ROE 13.58%
Debt/Equity 0.44
Chartmill High Growth Momentum
EPS Q2Q%3.62%
Sales Q2Q%12.18%
EPS 1Y (TTM)147.03%
Revenue 1Y (TTM)1.78%

FF.MI Forecast & Estimates

11 analysts have analysed FF.MI and the average price target is 12.51 EUR. This implies a price increase of 27.54% is expected in the next year compared to the current price of 9.81.

For the next year, analysts expect an EPS growth of 53.89% and a revenue growth 5.61% for FF.MI


Analysts
Analysts85.45
Price Target12.51 (27.52%)
EPS Next Y53.89%
Revenue Next Year5.61%

FF.MI Ownership

Ownership
Inst Owners12%
Ins Owners53.17%
Short Float %N/A
Short RatioN/A

About FF.MI

Company Profile

FF logo image Fine Foods & Pharmaceuticals N.T.M. The company is headquartered in Verdellino, Bergamo and currently employs 660 full-time employees. The company went IPO on 2016-10-19. The company is specialized in the manufacturing of pharmaceutical products for third parties. The firm manages three segments: Pharmaceuticals, Nutraceuticals and Medical Devices. The Pharmaceuticals segment includes powders and granules, tablets, coated tablets and hard gelatin capsules, packaged in sachets, blisters and bottles. The Nutraceuticals segment includes soluble and effervescent powders and granules, soluble, effervescent and chewable tablets, coated tablets and hard gelatin capsules packaged in bags, sachets, sticks, jars, tablet bottles, blisters and strips. The Medical Devices segment includes tablets, capsules, powders, granules and cover the areas for gastrointestinal, oral and throat treatment and the weight management. Medical Devices marked CE (European Conformity) are available for licensing.

Company Info

FINE FOODS & PHARMACEUTICALS

Via Berlino, 39, Zingonia

Verdellino BERGAMO IT

Employees: 779

FF Company Website

FF Investor Relations

Phone: 390354821382

FINE FOODS & PHARMACEUTICALS / FF.MI FAQ

What does FF do?

Fine Foods & Pharmaceuticals N.T.M. The company is headquartered in Verdellino, Bergamo and currently employs 660 full-time employees. The company went IPO on 2016-10-19. The company is specialized in the manufacturing of pharmaceutical products for third parties. The firm manages three segments: Pharmaceuticals, Nutraceuticals and Medical Devices. The Pharmaceuticals segment includes powders and granules, tablets, coated tablets and hard gelatin capsules, packaged in sachets, blisters and bottles. The Nutraceuticals segment includes soluble and effervescent powders and granules, soluble, effervescent and chewable tablets, coated tablets and hard gelatin capsules packaged in bags, sachets, sticks, jars, tablet bottles, blisters and strips. The Medical Devices segment includes tablets, capsules, powders, granules and cover the areas for gastrointestinal, oral and throat treatment and the weight management. Medical Devices marked CE (European Conformity) are available for licensing.


Can you provide the latest stock price for FINE FOODS & PHARMACEUTICALS?

The current stock price of FF.MI is 9.81 EUR. The price increased by 0.93% in the last trading session.


What is the dividend status of FINE FOODS & PHARMACEUTICALS?

FINE FOODS & PHARMACEUTICALS (FF.MI) has a dividend yield of 1.5%. The yearly dividend amount is currently 0.12.


What is the ChartMill technical and fundamental rating of FF stock?

FF.MI has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 6 out of 10.


What is the analyst forecast for FF.MI stock?

11 analysts have analysed FF.MI and the average price target is 12.51 EUR. This implies a price increase of 27.54% is expected in the next year compared to the current price of 9.81.


Can you provide the growth outlook for FINE FOODS & PHARMACEUTICALS?

The Revenue of FINE FOODS & PHARMACEUTICALS (FF.MI) is expected to grow by 5.61% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.